Bibliografia UJ CM

1/3
P.D. Miller, R.R. Recker, J.-Y. Reginster, B.J. Riss, E[dward] Czerwinski, D. Masanauskaite, A. Kenwright, R. Lorenc, J.A. Stakkestad, P. Lakatos.
Efficacy of monthly oral ibandronate is sustained over 5 years : the MOBILE long-term extension study.
Osteoporosis International
2012 : Vol. 23, nr 6, s. 1747-1756, il., bibliogr. 25 poz., abstr.
p-ISSN: 0937-941X
AZ
ORG
AIF
IF: 4.039
2/3
G. Bianchi, E[dward] Czerwinski, A. Kenwright, A. Burdeska, R.R. Recker, D. Felsenberg.
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis : 5-year data from the DIVA study long-term extension.
Osteoporosis International
2012 : Vol. 23, nr 6, s. 1769-1778, il., bibliogr. 40 poz., abstr.
p-ISSN: 0937-941X
AZ
ORG
AIF
IF: 4.039
3/3
R.R. Recker, L[ouis] G. Ste-Marie, E[dward] Czerwinski, L. Rowell, B. Bonvoisin, D. Masanauskaite, D. Felsenberg.
Intermittent intravenous ibandronate injections have a similar bone safety profile to daily oral dosing.
Calcif. Tissue Int.
2006 : Vol. 78 suppl. 1, s. S156, abstr. P455
33rd European Symposium on Calcified Tissues, Prague, Czech Republic, 10-14 May 2006.
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ